ORIX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.6 USD | -0.49% |
|
+1.45% | +14.13% |
| 09/05 | Japanese shares rises on value stocks' appeal as rate hike looms | RE |
| 08/05 | Orix's Attributable Profit Up 19.2% in Fiscal 2024 | MT |
Strengths
- With a P/E ratio at 11.58 for the current year and 9.79 for next year, earnings multiples are highly attractive compared with competitors.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- One of the major weak points of the company is its financial situation.
- The company's enterprise value to sales, at 3.09 times its current sales, is high.
- Revenue estimates are regularly revised downwards for the current and coming years.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Consumer Lending
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +14.13% | 24.58B | - | ||
| -8.90% | 49.72B | C+ | ||
| -6.49% | 30.42B | C+ | ||
| +51.30% | 25.97B | - | - | |
| +18.30% | 18.03B | B | ||
| -0.61% | 12.9B | C+ | ||
| +13.52% | 10.35B | B- | ||
| +13.62% | 8.13B | C | ||
| -24.92% | 7.52B | - | ||
| +32.35% | 6.23B | C- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 8591 Stock
- IX Stock
- Ratings ORIX Corporation